Literature DB >> 30085940

SATB2 is Consistently Expressed in Squamous Morules Associated With Endometrioid Proliferative Lesions and in the Stroma of Atypical Polypoid Adenomyoma.

W Glenn McCluggage1, Koen Van de Vijver.   

Abstract

So-called squamous morules are closely associated with endometrioid proliferative lesions, in the endometrium and the ovary. Morules have an unusual immunophenoptype, typically exhibiting nuclear staining with β-catenin, positivity with CDX2, CD10, and p16 and are negative with hormone receptors and p63. We report the previously undescribed occurrence of consistent SATB2 nuclear positivity within morules. Nuclear positivity was present in 38/43 (88%) cases of morules (24 focal; 14 diffuse) while all cases of nonmorular squamous metaplasia in endometrioid proliferative lesions (n=13) were SATB2 negative, except for occasional positive nuclei in 1 case. We also observed that the stromal cells of atypical polypoid adenomyoma typically exhibited diffuse nuclear immunoreactivity with SATB2 while the stromal cells of other endometrial polypoid lesions (endometrial polyp, adenomyoma, adenosarcoma) were usually negative, although there was focal weak staining in occasional cases. Pathologists should be aware of this previously undescribed phenomenon which represents a further example of the unusual immunophenotype of so-called squamous morules. The reasons underlying SATB2 nuclear positivity in squamous morules and the stroma of atypical polypoid adenomyoma are unknown.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30085940     DOI: 10.1097/PGP.0000000000000544

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  4 in total

1.  A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma.

Authors:  Cécile Le Page; Martin Köbel; Liliane Meunier; Diane M Provencher; Anne-Marie Mes-Masson; Kurosh Rahimi
Journal:  J Pathol Clin Res       Date:  2019-04-20

Review 2.  SATB2 is a novel biomarker and therapeutic target for cancer.

Authors:  Sanjit K Roy; Anju Shrivastava; Sudesh Srivastav; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Cell Mol Med       Date:  2020-09-04       Impact factor: 5.310

3.  Value of Transabdominal Combined Transvaginal Color Doppler Ultrasonography in the Distinguish between Uterine Adenomyoma and Uterine Fibroids.

Authors:  Hongmei Qi; Changjiang Zhou; Zhenyi Huang; Na Yang; Qun Wu
Journal:  Biomed Res Int       Date:  2022-07-07       Impact factor: 3.246

4.  Does endometrial morular metaplasia represent odontogenic differentiation?

Authors:  Antonio Travaglino; Antonio Raffone; Daniela Russo; Elia Guadagno; Sara Pignatiello; Paola Moretta; Fulvio Zullo; Marialaura Del Basso De Caro; Luigi Insabato; Massimo Mascolo
Journal:  Virchows Arch       Date:  2021-03-05       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.